INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Brain & Mood desk →

1,209 studies · page 51 of 51

1989 / Controlled trial

Mirthful laughter reduced serum levels of cortisol, dopac, epinephrine, and growth hormone in healthy men.

Ten healthy male subjects were split into an experimental group that watched a 60-minute humor video (n=5) and a control group that did not (n=5). Serial blood samples were measured for various neuroendocrine and stress hormones. Cortisol and dopac decreased more rapidly from baseline in the experimental group compared to controls (p = 0.011 and p = 0.025, respectively), and epinephrine was significantly lower at all time points (p = 0.017). Growth hormone decreased significantly with the laughter intervention (p < 0.0005), whereas ACTH, beta-endorphin, prolactin, and norepinephrine levels did not significantly increase.

Berk LS, Tan SA, Fry WF, et al. Am J Med Sci, 1989. PMID 2556917

1989 / Inpatient interventional study

A carbohydrate-rich, protein-poor evening meal improved late-luteal mood scores in women with premenstrual syndrome.

Researchers assessed mood and direct calorie/nutrient intake in 19 patients with severe premenstrual syndrome and 9 controls during early follicular and late luteal phases. During the late luteal phase, PMS patients increased calorie intake from 1892 +/- 104 to 2395 +/- 93 kcal, with carbohydrate intake increasing 24% from meals and 43% from snacks, while Hamilton Depression Scale scores rose from 2.0 +/- 0.5 to 21.2 +/- 0.8. Consumption of a carbohydrate-rich, protein-poor evening test meal in the late luteal phase significantly improved depression, tension, anger, confusion, sadness, fatigue, alertness, and calmness scores (p < 0.01) in PMS patients, with no effect seen in the follicular phase or in controls.

Wurtman JJ, Brzezinski A, Wurtman RJ, et al. Am J Obstet Gynecol, 1989. PMID 2589444

1987 / Interventional dietary study

Dietary protein intake altered plasma large neutral amino acid levels and correlated with motor fluctuations in patients with Parkinson's disease on levodopa.

Seven patients with Parkinson's disease experiencing severe motor fluctuations on levodopa were evaluated under various dietary protein conditions without changes to their levodopa dosage. Regular and high-protein diets increased plasma large neutral amino acid (LNAA) levels, leading to parkinsonian symptoms despite elevated plasma levodopa. Symptoms were relieved when amino acid levels dropped while levodopa remained elevated. On a low-protein diet, LNAA levels remained low and patients were consistently dyskinetic throughout the day despite slightly lower mean plasma levodopa. A redistribution diet with virtually no protein until supper allowed near-normal daytime motor function.

Pincus JH, Barry KM Arch Neurol, 1987. PMID 3632370

1986 / Interventional crossover case study

Intravenous amino acid loading significantly reduced brain uptake of L-[18F]fluorodopa in a healthy human subject.

Brain uptake of L-[18F]fluorodopa was measured using positron emission tomography in one healthy male volunteer under fasting conditions and during intravenous amino acid loading. A significant reduction of tracer uptake into the brain was demonstrated during amino acid loading. This provides in vivo human evidence for competition between L-dopa and other amino acids across the blood-brain barrier.

Leenders KL, Poewe WH, Palmer AJ, et al. Ann Neurol, 1986. PMID 3092728

1986 / Randomized controlled trial

In women on a 1,000 kcal diet, a vegetarian diet resulted in significantly better global mood than a mixed diet over the final three weeks.

Healthy young women of normal weight followed a 1,000 kcal per day weight-reducing diet for six weeks with divergent dietary instructions to achieve a broad range of macronutrient intake. Global mood during the final three weeks was significantly better in the vegetarian diet group compared to the mixed diet group. During this period, global mood correlated significantly with relative carbohydrate intake (r = -0.74; p < 0.01) and with the ratio of plasma tryptophan to other large neutral amino acids (r = -0.52; p < 0.05).

Schweiger U, Laessle R, Kittl S, et al. J Neural Transm, 1986. PMID 3783150

1982 / Intervention study / case series and animal study

Nicotinamide inhibited the metabolism of primidone and increased carbamazepine levels in humans.

The effect of nicotinamide on the conversion of primidone to phenobarbital was examined in mice and three epileptic patients. In mice, 200 mg/kg of nicotinamide increased primidone's half-life by 47.6% and decreased conversion to phenobarbital and phenylethylmalonamide by 32.4% and 14.5%, respectively. In patients, nicotinamide decreased the conversion of primidone to phenobarbital, with dose correlating directly with the primidone-phenobarbital ratio (r = 0.861, p < 0.01). Nicotinamide also increased carbamazepine levels in two patients.

Bourgeois BF, Dodson WE, Ferrendelli JA Neurology, 1982. PMID 6214728

1980 / Randomized controlled trial

Prenatal high protein supplementation was linked to early premature births and neonatal deaths, while balanced protein-calorie supplementation showed mixed effects.

A randomized controlled trial evaluated prenatal nutritional supplementation among poor urban black mothers at high risk for low birth weight infants. At birth, the only significant favorable effect observed was the prevention of depressed birth weight in offspring of mothers who smoked heavily. Balanced protein-calorie supplementation increased gestation length, reduced low-birth-weight infants, and non-significantly raised mean birth weight by 41 gm. High protein supplementation led to an excess of very early premature births, associated neonatal deaths, and significant growth retardation up to 37 weeks; at 1 year, it affected three psychological measures (visual habituation, visual dishabituation, and mean length of free play episodes) with no detectable residual adverse effects.

Rush D, Stein Z, Susser M Pediatrics, 1980. PMID 6988785

1979 / Interventional study

A study of 380 patients undergoing fasting therapy reported an 87% clinical efficacy rate along with shifts in EEG patterns and hormonal suppression.

The Tohoku University method of fasting therapy was evaluated in 380 patients, alongside physiological testing before, during, and after the intervention. The therapy yielded an efficacy rate of 87%, showing good indications for irritable colon syndrome, neurocirculatory asthenia, mild diabetes mellitus, obesity, and borderline hypertension. EEG peak frequency decreased during fasting and increased during refeeding, with post-fasting percent energy of alpha waves significantly higher than pre-fasting levels. Additionally, the dexamethasone suppression rate of urine 17-OHCS was significantly lower after fasting therapy than before.

Yamamoto H, Suzuki J, Yamauchi Y Psychother Psychosom, 1979. PMID 550177

1976 / Interventional study

A 10-day complete fasting therapy regimen achieved an 87% efficacy rate in patients with psychosomatic diseases.

A 10-day complete fasting protocol with IV vitamins and fluids, bed rest, and meditation was evaluated in 262 patients with internal medicine psychosomatic diseases. Clinical and laboratory evaluations were conducted throughout the fasting and 5-day refeeding period. An efficacy rate of 87% with excellent prognosis was attained, identifying conditions such as irritable colon, borderline hypertension, mild diabetes, and obesity as suitable indications.

Suzuki J, Yamauchi Y, Horikawa M, et al. Tohoku J Exp Med, 1976. PMID 964029